Evidence and Research

Trials have shown that daily oral PrEP works if taken correctly and consistently. But there’s still a lot to learn about how to deliver oral PrEP.

The safety and efficacy of daily oral tenofovir-based PrEP is well-established. Policy and program decisions are guided by both data from the original randomized clinical trials as well as newer studies. Demonstration projects, implementation initiatives and national rollout provide information about challenges and opportunities with oral PrEP delivery, and can help optimize services and identify gaps.

Read below to find out more about:

Clinical Trials Evidence
Open Label and Demonstration Project Evidence
Findings from National Introduction and Scale-Up